Contact us
Precision Medicine
What is von hippel-lindau disease?
11 December 2025
This is a low-incidence hereditary condition characterized by the abnormal growth of non-cancerous tumors and cysts that can develop in various parts of the body but may, at some point, become malignant.
The sooner Von Hippel-Lindau (VHL) disease is diagnosed, the more the risks and complications are minimized.
The tumors begin to appear in adulthood, primarily in the:
- Brain.
- Adrenal glands.
- Spinal cord.
- Ears.
- Pancreas.
- Kidneys.
People with VHL disease have an increased risk of developing tumors in areas that contain blood vessels.
Signs and symptoms Von Hippel-Lindau Disease
The symptoms manifest based on the size and location of the tumors, but they usually include:
- Headache (Migraine).
- Weak limbs.
- Difficulty walking.
- High blood pressure (Hypertension).
- Nausea.
- Hearing loss.
- Loss of balance.
- Vision disorders.
- Vertigo.
- Vomiting.
Early detection and treatment are essential to prevent permanent damage, as VHL disease can cause blindness, brain damage, and even death.
Diagnosis and treatment Von Hippel-Lindau Disease
Once the doctor analyzes the symptoms and clinical history, they will perform a physical exam and conduct a series of tests to confirm the diagnosis, such as:
- Genetic tests.
- Magnetic resonance imaging (MRI).
- Computed tomography (CT) scan.
Treatment for VHL disease depends on the location and size of the tumor or tumors, but generally includes:
- Surgical procedure to remove the tumors.
- Radiation therapy.
Since its inauguration in 2009, our Cancer Center has offered chemotherapy and radiation therapy treatments on par with the best medical centers in the world through a comprehensive care model for the oncology patient.
Related centers and departments Von Hippel-Lindau Disease
Fuentes:
- cancer.org
- cancer.net
- cancer.gov
- stjude.org
- elsevier.es
- mayoclinic.org
- medlineplus.gov
- msdmanuals.com
- medigraphic.com
- Solís AL, Alemany RE. Carcinomas renales múltiples como manifestación inicial del Síndrome de Von Hippel Lindau. Presentación de caso. Revista Habanera de Ciencias Médicas. 2017;16(5):751-760.
- Díaz SMJ, Castro SJ, Conde CB, et al. Síndrome de Von Hippel-Lindau. Acta Med. 2023;21(2):167-169. doi:10.35366/110266.
- Uscanga-Yépez J, Rodríguez-Covarrubias F, Morales J, et al. Tratamiento quirúrgico del carcinoma de células renales en la enfermedad de von Hippel-Lindau. Rev Invest Clin. 2013;65(4):318-322.
How can we help you?